The efficacy of rituximab in patients with splenectomized refractory chronic ITP
Dátum: 30.10.2009 16:48 Vec: Trombocytopenia
The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura
Semir Pasa1, Abdullah Altintas1, Timucin Cil2, Ramazan Danis3 and Orhan Ayyildiz1
(1) Department of Hematology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
(2) Department of Oncology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
(3) Department of Nephrology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
J Thromb Thrombolysis (2009) 27:329-333
Keywords Refractory chronic idiopathic thrombocytopenic purpura - Splenectomy - Anti-CD20 monoclonal antibody - Rituximab
pozri abstrakt
|
|